Hologic Aktie

Hologic für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 879100 / ISIN: US4364401012

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
31.07.2025 11:03:02

Hologic (HOLX) Q3 Revenue Beats 1%

Hologic (NASDAQ:HOLX), a global medical technology company specializing in diagnostics and women’s health, reported financial results for the third quarter of fiscal 2025 on July 30, 2025. The most notable headline: both GAAP revenue and non-GAAP earnings per share came in ahead of expectations, with GAAP revenue at $1,023.8 million compared to the $1,008.6 million analyst consensus, and non-GAAP earnings per share of $1.08 versus the $1.06 forecast. These figures beat both external analyst and company guidance (non-GAAP). The company continued to generate strong operating cash flow, though Organic revenue growth and margins faced headwinds in certain segments, particularly in Breast Health. Overall, Hologic posted a mixed quarter with clear outperforming areas, but underlying pressure in some key markets and business lines. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q2 2025 earnings report. Hologic is a leading developer and manufacturer of medical devices and diagnostic products, with a core focus on women’s health. Its main business segments are Diagnostics, Breast Health, Surgical, and Skeletal Health.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu Hologic IncShsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Hologic IncShs 57,50 0,00% Hologic IncShs